FDA approves Lap-Band for millions more patients

Feb 16, 2011

(AP) -- Cosmetic drug and device maker Allergan Inc. says it has received approval to market its stomach-shrinking Lap-Band to millions more patients who are less obese than those currently using the device.

The expanded approval to patients with a between 30 and 40 and one weight-related medical condition, such as . Patients must also have previously attempted other weight loss strategies, like diet and exercise.

Allergan said roughly 37 million American patients meet the new criterion for the device. The adjustable band has been available in the U.S. since 2001.

A ring is placed over the top of the stomach and inflated with saline to tighten it and restrict how much food can enter and pass through the stomach.

Explore further: Medical charity accuses US of pushing India to ease patent rules

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Panel recommends expanding use of stomach bands

Dec 04, 2010

(AP) -- About 12 million more obese Americans could soon qualify for surgery to implant a small, flexible stomach band designed to help them lose weight by dramatically limiting their food intake. The Food ...

FDA approves Botox for migraine headaches

Oct 15, 2010

(AP) -- Federal health officials approved the wrinkle-smoothing injection Botox for migraine headaches on Friday, giving drugmaker Allergan clearance to begin marketing its drug to patients with a serious history of the ...

No scars: New obesity surgery goes through mouth

Jun 03, 2009

(AP) -- Doctors are testing a new kind of obesity surgery without any cuts through the abdomen, snaking a tube as thick as a garden hose down the throat to snap staples into the stomach. The experimental, ...

Soft drink could enhance effects of an anti-cancer drug

Oct 13, 2010

Experiments with an artificial stomach suggest that a popular lemon-lime soft drink could play an unexpected role in improving the effectiveness of an oral anticancer drug. The experiments produced evidence that patients ...

Recommended for you

Ebola vaccine not before late 2016: GSK researcher

Oct 17, 2014

An Ebola vaccine by British pharmaceuticals giant GlaxoSmithKline may not be ready for commercial use until late 2016 and should therefore not be seen as the "primary answer" to the current outbreak, a company researcher ...

Chimerix gets FDA OK to test drug for Ebola

Oct 17, 2014

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Esbriet, ofev approved to treat deadly lung disease

Oct 16, 2014

(HealthDay)—Two new drugs have been approved by the U.S. Food and Drug Administration to treat progressive lung scarring from an uncertain cause, medically called idiopathic pulmonary fibrosis (IPF).

FDA weighs removing bolded warning from Chantix

Oct 14, 2014

(AP)—The Food and Drug Administration will ask a panel of experts later this week whether a bold-letter warning on the anti-smoking drug Chantix should be removed based on company-supported evidence that the drug does not ...

Drug-coated balloon catheter approved

Oct 13, 2014

(HealthDay)—The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been approved by the U.S. Food and Drug Administration.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

neiorah
not rated yet Feb 18, 2011
Why do they have to have diabetes first. Use it as a preventative measure since weight caused diabetes is caused by too much sugar and a resistance to insulin. Not good to wait until after the damage is done.